Blair William & CO Sellas Life Sciences Group, Inc. Transaction History
Blair William & CO
- $34.8 Billion
- Q2 2025
A detailed history of Blair William & CO transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Blair William & CO holds 16,002 shares of SLS stock, worth $25,763. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,002Holding current value
$25,763% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding SLS
# of Institutions
69Shares Held
21.7MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$12.2 Million1.95% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.65MShares$10.7 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.2MShares$3.54 Million0.0% of portfolio
-
Nuveen, LLC Charlotte, NC971KShares$1.56 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.11 Million0.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $33.1M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...